Pfizer Inc.
US ˙ NYSE ˙ US7170811035

SecurityPFE / Pfizer Inc.
InstitutionVan Eck Associates Corp
Latest Disclosed Ownership16,301,030 shares
Latest Disclosed Value $ 457,733
Van Eck Associates Corp reports 22.17% increase in ownership of PFE / Pfizer Inc.

On May 15, 2026 - Van Eck Associates Corp filed a 13F-HR form disclosing ownership of 16,301,030 shares of Pfizer Inc. (US:PFE) valued at $457,732,922 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 13,342,760 shares of Pfizer Inc.. This represents a change in shares of 22.17% during the quarter. The current value of the position is $413,068,100 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Pfizer COM 717081103 16,301,030 2,958,270 22.17 458 37.65 0.2999
2026-02-13 2025-12-31 13F Pfizer COM 717081103 13,342,760 -4,813,780 -26.51 332 -28.14 0.2746
2025-11-13 2025-09-30 13F Pfizer COM 717081103 18,156,540 -4,744,499 -20.72 463 -16.76 0.4298
2025-08-14 2025-06-30 13F Pfizer COM 717081103 22,901,039 795,423 3.60 555 -0.89 0.6283
2025-05-15 2025-03-31 13F Pfizer COM 717081103 22,105,616 818,811 3.85 560 -0.71 0.7241
2025-01-29 2024-12-31 13F Pfizer COM 717081103 21,286,805 4,726,549 28.54 565 18.24 0.7231
2024-10-29 2024-09-30 13F Pfizer COM 717081103 16,560,256 456,168 2.83 478 6.00 0.5968
2024-07-31 2024-06-30 13F Pfizer COM 717081103 16,104,088 290,760 1.84 451 2.74 0.6403
2024-04-30 2024-03-31 13F Pfizer COM 717081103 15,813,328 2,829,178 21.79 439 17.43 0.6633
2024-02-05 2023-12-31 13F Pfizer COM 717081103 12,984,150 3,265,276 33.60 374 15.84 0.6802
2023-11-08 2023-09-30 13F Pfizer COM 717081103 9,718,874 2,273,275 30.53 322 17.95 0.7074
2023-08-03 2023-06-30 13F Pfizer COM 717081103 7,445,599 3,601,529 93.69 273 75.00 0.5977
2023-05-03 2023-03-31 13F Pfizer COM 717081103 3,844,070 2,326,950 153.38 157 102.60 0.3571
2023-02-08 2022-12-31 13F Pfizer COM 717081103 1,517,120 1,062 0.07 78 -99.88 0.2008
2022-10-27 2022-09-30 13F Pfizer COM 717081103 1,516,058 207,989 15.90 66,342 -3.27 0.1974
2022-08-03 2022-06-30 13F Pfizer COM 717081103 1,308,069 852,451 187.10 68,582 190.75 0.1818
2022-05-10 2022-03-31 13F Pfizer COM 717081103 455,618 -31,474 -6.46 23,588 -17.99 0.0487
2022-01-26 2021-12-31 13F Pfizer COM 717081103 487,092 -2,476,151 -83.56 28,763 -77.43 0.0665
2021-11-03 2021-09-30 13F Pfizer COM 717081103 2,963,243 -1,878,344 -38.80 127,449 -32.78 0.3204
2021-08-10 2021-06-30 13F Pfizer COM 717081103 4,841,587 174,809 3.75 189,597 12.14 0.4486
2021-05-13 2021-03-31 13F Pfizer COM 717081103 4,666,778 1,251,532 36.65 169,077 34.49 0.4599
2021-02-09 2020-12-31 13F Pfizer COM 717081103 3,415,246 40,676 1.21 125,715 1.51 0.3661
2020-12-04 2020-09-30 13F/A-1 Pfizer COM 717081103 3,374,570 176,988 5.54 123,846 18.44 0.3941
2020-11-12 2020-09-30 13F Pfizer COM 717081103 3,374,570 176,988 123,846 383,966.4328
2020-08-14 2020-06-30 13F/A-1 Pfizer COM 717081103 3,197,582 360,262 12.70 104,561 12.90 0.3642
2020-08-10 2020-06-30 13F Pfizer COM 717081103 3,197,582 360,262 104,561 355,220.0007
2020-05-12 2020-03-31 13F Pfizer COM 717081103 2,837,320 88,099 3.20 92,610 -14.02 0.4703
2020-02-13 2019-12-31 13F Pfizer COM 717081103 2,749,221 1,638,466 147.51 107,715 169.90 0.4161
2019-11-08 2019-09-30 13F Pfizer COM 717081103 1,110,755 218,235 24.45 39,909 3.22 0.1870
2019-08-07 2019-06-30 13F Pfizer COM 717081103 892,520 7,515 0.85 38,664 2.87 0.1863
2019-05-13 2019-03-31 13F Pfizer COM 717081103 885,005 -71,378 -7.46 37,586 -9.97 0.1846
2019-02-12 2018-12-31 13F Pfizer COM 717081103 956,383 -496,151 -34.16 41,746 -34.79 0.2094
2018-11-13 2018-09-30 13F Pfizer COM 717081103 1,452,534 -48,621 -3.24 64,013 17.54 0.3122
2018-08-13 2018-06-30 13F Pfizer COM 717081103 1,501,155 161,589 12.06 54,462 14.56 0.2546
2018-05-11 2018-03-31 13F Pfizer COM 717081103 1,339,566 38,198 2.94 47,541 0.86 0.2363
2018-02-12 2017-12-31 13F Pfizer COM 717081103 1,301,368 -58,889 -4.33 47,136 -2.93 0.2325
2017-11-09 2017-09-30 13F Pfizer COM 717081103 1,360,257 460,062 51.11 48,561 60.60 0.2481
2017-08-11 2017-06-30 13F Pfizer COM 717081103 900,195 1,520 0.17 30,238 -1.65 0.1653
2017-05-11 2017-03-31 13F Pfizer COM 717081103 898,675 -19,735 -2.15 30,744 3.06 0.1355
2017-02-09 2016-12-31 13F Pfizer COM 717081103 918,410 575,003 167.44 29,830 156.47 0.1486
2016-11-14 2016-09-30 13F Pfizer COM 717081103 343,407 -31,229 -8.34 11,631 -11.83 0.0541
2016-08-12 2016-06-30 13F Pfizer COM 717081103 374,636 -61,054 -14.01 13,191 2.14 0.0676
2016-05-13 2016-03-31 13F Pfizer COM 717081103 435,690 -172,983 -28.42 12,914 -34.27 0.0870
2016-02-12 2015-12-31 13F Pfizer COM 717081103 608,673 53,572 9.65 19,648 12.69 0.1559
2015-11-12 2015-09-30 13F Pfizer COM 717081103 555,101 -66,353 -10.68 17,436 -16.32 0.1340
2015-08-12 2015-06-30 13F Pfizer COM 717081103 621,454 -50,195 -7.47 20,837 -10.83 0.1232
2015-05-14 2015-03-31 13F Pfizer COM 717081103 671,649 -9,751 -1.43 23,367 10.09 0.1349
2015-02-13 2014-12-31 13F Pfizer COM 717081103 681,400 -316,416 -31.71 21,226 -28.06 0.1320
2014-11-14 2014-09-30 13F Pfizer COM 717081103 997,816 147,058 17.29 29,505 16.85 0.1563
2014-08-14 2014-06-30 13F PFIZER COM 717081103 850,758 130,485 18.12 25,250 9.14 0.1165
2014-05-08 2014-03-31 13F PFIZER COM 717081103 720,273 115,710 19.14 23,135 24.93 0.1148
2014-02-12 2013-12-31 13F PFIZER COM 717081103 604,563 717 0.12 18,518 6.76 0.0935
2013-11-14 2013-09-30 13F PFIZER COM 717081103 603,846 -165,875 -21.55 17,345 -19.55 0.0883
2013-08-14 2013-06-30 13F PFIZER COM 717081103 769,721 769,721 21,560 0.1175
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.